JOURNAL ARTICLES
Gupta SK, Falk GW, Aceves SS, et al. Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration. Gastroenterology 2019;156:838-842.
Hirano I, Dellon ES, Hamilton JD, et al. Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis. Gastroenterology 2019;Oct 5. pii: S0016-5085(19)41415-7. doi: 10.1053/j.gastro.2019.09.042.
Hirano I, Collins MH, Assouline-Dayan Y, et al. IL13に対するモノクローナル抗体であるRPC4046は、好酸球性食道炎患者の組織学的および内視鏡的活動を低下させます。 Gastroenterology 2019;156:592-603 e10.
Azouz NP, Ynga-Durand MA, Caldwell JM, et al. The antiprotease SPINK7 serves an inhibitory checkpoint for esophageal epithelial inflammatory responses. Sci Transl Med 2018;10.
Dellon ES, Liacouras CA, Molina-Infante J, et al.Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis（好酸球性食道炎の国際的なコンセンサス診断基準）。 Proceedings of the AGREE Conference. Gastroenterology 2018.
Shoda T, Wen T, Aceves SS, et al. Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study. Lancet Gastroenterol Hepatol 2018;3:477-488.
Davis BP, Rothenberg ME. 好酸球性食道炎の疾患のメカニズム。 Annu Rev Pathol. 2016 May 23; 11:365-93
Rothenberg ME. ヒト化抗IL-5抗体療法。 Cell. 2016;165:509.
Davis BP、Stucke EM、Khorki ME、Litosh VA、Rymer JK、Rochman M、Travers J、Kottyan LC、Rothenberg ME. 好酸球性食道炎関連カルパイン14は、食道上皮バリアー障害を媒介するIL-13誘導性プロテアーゼである。 JCI Insight 2016; 1:e86355.
Wen T, Dellon ES, Moawad FJ, Furuta GT, Aceves SS, Rothenberg ME. プロトンポンプ阻害剤対応の食道好酸球症のトランスクリプトーム解析により、プロトンポンプ阻害剤可逆的なアレルギー性炎症が明らかになりました。 J Allergy Clin Immunol. 2015;135:187-97.
Rothenberg ME. Molecular, genetic, and cellular bases for treating eosinophilic esophagitis（好酸球性食道炎を治療するための分子、遺伝子、細胞の基盤）。 Gastroenterology. 2015;148:1143-57.
Molina-Infante J, Bredenoord AJ, Cheng E, Dellon ES, Furuta GT, Gupta SK, Hirano I, Katzka DA, Moawad FJ, Rothenberg ME, Schoepfer A, Spechler S, Wen T, Straumann A, Lucendo AJ. プロトンポンプインヒビターに反応する食道好酸球症：現在の好酸球性食道炎の診断基準に疑問を投げかける存在である。 Gut. 2015; 65:524-31.
Kottyan LC, Davis BP, Sherrill JD Liu K, Rochman M, Kaufman K, Weirauch MT, Vaughn S, Lazaro S, Rupert AM, Kohram M, Stucke EM, Kemme KA, Magnusen A, He H, Dexheimer P, Chehade M, Wood RA, Pesek RD, Vickery BP, Fleischer DM, Lindbad R, Sampson HA, Mukkada VA, Putnam PE, Abonia JP, Martin LJ, Harley JB, Rothenberg ME. 好酸球性食道炎のゲノムワイド関連解析により、このアレルギー性疾患の組織特異性についての知見が得られました。 Nat Genet. 2014;46:895-900.
Alexander ES、Martin LJ、Collins MH、Kottyan LC、Sucharew HJ、He H、Mukkada VA、Succop PA、Pablo JP、Foote H、Eby MD、Grotjan TM、Greenler AJ, Dellon ES, Demain JG, Furuta GT, Gurian LE, Harley JB, Hopp RJ, Kagalwalla A, Kaul A, Nadeau KC, Noel RJ, Putnam PR, von Tiehl KF, Rothenberg ME. 双子と家族の研究から、好酸球性食道炎の高い遺伝率を説明する強い環境的手がかりと弱い遺伝的手がかりが明らかになりました。 J Allergy Clin Immunol. 2014;134:1084-92.e1
Scheeren FA, Kuo AH, van Weele LJ, Cai S, Glykofridis I, Sikandar SS, Zabala M, Qian D, Lam JS, Johnston D, Volkmer JP, Sahoo D, van de Rijn M, Dirbas FM, Somlo G, Kalisky T, Rothenberg ME, Quake SR, Clarke MF. A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelial and oncogenesis. Nat Cell Biol.2014;16:1238-48
Henderson CJ, Abonia JP, King EC, Putnam PE, Collins MH, Franciosi JP, Rothenberg ME.Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol.
Bochner BS, Book W, Busse WW, Butterfield J, Furuta GT, Gleich GJ, Klion AD, Lee JJ, Lieferman KM, Minnicozzi M, Moqbel R, Rothenberg ME, Schwartz LB, Simon HU, Wechsler ME, Weller PF.Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD). J Allergy Clin Immunol. 2012:130:587-96.
Rothenberg ME, Aceves S, Bonis PA, Collins MH, Gonsalves N, Gupta SK, Hirano I, Liacouras CA, Putnam PE, Spergel JM, Straumann A, Wershil BK, Furuta GT. 米国食品医薬品局との連携：好酸球性食道炎患者の理解と治療における進捗状況とタイムライン。 J Allergy Clin Immunol. 2012;130:617-9.
Sherrill JD, Rothenberg ME.Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies. J Allergy Clin Immunol. 2011;128:23-32; quiz 33-4.
DeBrosse CW, Franciosi JP, King EC, Butz BK, Greenberg AB, Collins MH, Abonia JP, Assa’ad A, Putnam PE, Rothenberg ME. 小児に発症した食道好酸球症の長期成績。 J Allergy Clin Immunol. 2011;128:132-8.
Liacouris C, Furuta GT, Hirano I, et al: Liacouris C., Furuta GT, Hirano I, et al. J Allergy Clin Immunol. 2011;128:3-20
Rothenberg ME. Biology and treatment of eosinophilic esophagitis（好酸球性食道炎の生物学と治療）. Gastroenterology. 2009;137:1238-1249
Blanchard C, Wang N, Stringer, et al. Eotaxin-3 and a uniquely conserved gen-expression profile in eosinophilic esophagitis（好酸球性食道炎におけるEotaxin-3とユニークに保存された遺伝子発現プロファイル）。 J Clin Invest. 2006;116:536-547。
Rothenberg ME. 好酸球性胃腸障害（EGID）。 J Allergy Clin Immunol. 2004;113:11-28.
Noel RJ, Putman PE, Rothenberg ME. 好酸球性食道炎 N Engl J Med. 2004;351:940-941.
Straumann A, et al. 原発性好酸球性食道炎の自然史：30人の成人患者を最大11.5年間追跡調査した結果。 Gastroenterology.
Cheung KM, Oliver MR, Cameron DJ, et al. Esophage eosinophilia in children with dysphagia J Pediatr Gastroenterol Nutr.
Fox VL, Nurko S, Furuta GT. Gastrointest Endosc. Gastrointest Endosc. 2002;56(2):260-70.
Orenstein SR, et al. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J. Gsstroenterol. 2000;95:1422-1430.
Walsh SV, et al. Allergic esophagitis in children: a clinicopathologicl entity Am J Surg Pathol.
Kelly KJ, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with amino acid-based formula. Gastroenterology. 1995;109:1503-1512.